Manufactured by: Mankind Pharma Limited Paonta Sahib, Sirmaur, Himachal Pradesh 173025, India For BluePoint Laboratories Product of France Revised: September 2025 Code No.: HP/Drugs/N-MB/17/195 NDC 68001-640-59 Cyanocobalamin Injection, USP Rx only 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 1 mL Multiple-Dose Vial Rev:10/24 Rev 09/25: NDC 68001-640-60 Cyanocobalamin Injection, USP Rx only 1,000 mcg/mL For Intramuscular or Subcutaneous Use Only 25 x 1 mL Multiple-Dose Vials Rev: 10/24 Rev: 09/25
E.LangD.Tufnell-BarretT.MilsomA
Europe Market Split by Country The GLP-1 diabetes treatment drugs market in Europe is projected to grow from USD 1,708.0 million in 2025 to USD 14,836.7 million by 2035, registering a CAGR of 23.3% over the forecast period
Choose a strategy rather than relying on willpower
Supplementation with micronutrients is the mainstay of treatment for AIG patients
Lipid nanoparticles (LNP) with mRNAs were injected into the tail vein of model animals at postoperative 7 and 14 days after tracheal administration of bleomycin
